Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products... Show more
LFVN is expected to report earnings to rise 11.08% to 13 cents per share on August 25
Q2'26
Est.
$0.13
Q1'26
Missed
by $0.07
Q4'25
Est.
$0.15
Q3'25
Missed
by $0.03
Q2'25
Beat
by $0.01
The last earnings report on May 06 showed earnings per share of 11 cents, missing the estimate of 18 cents. With 133.58K shares outstanding, the current market capitalization sits at 76.70M.